Our Cationic Polypeptides for RNA Delivery service supports research teams evaluating peptide- and polypeptide-based carriers for mRNA, siRNA, miRNA, and other RNA formats. Positively charged polypeptides can associate electrostatically with the phosphate backbone of RNA, condense cargo into nanoscale complexes, and provide a tunable platform for incorporating hydrophobic, targeting, or endosomal-disruption features. The same charge interactions that promote complexation, however, can also drive aggregation, serum interactions, incomplete RNA release, or cell-dependent tolerability issues.
We develop research-use carrier and formulation strategies around charge density, polymer length, side-chain composition, amphiphilicity, RNA type, N/P-type charge ratio, and buffer conditions. Projects can be integrated with our RNA drug delivery system, polymer-complex delivery workflows, or peptide–siRNA conjugation when the program requires comparison across delivery formats.
Figure 1. Cationic polypeptides-based mRNA carrier.
Over-Condensation of RNA: Strong cationic interactions can protect and compact RNA, but complexes that bind too tightly may release cargo inefficiently after uptake. Carrier composition and charge ratio must therefore be optimized around both loading and release.
Aggregation and Size Drift: RNA–polypeptide complexes can change size with concentration, salt, mixing order, and storage time. Formulation development should define practical preparation conditions rather than relying on a single endpoint measurement.
Endosomal Escape: Cellular uptake does not guarantee cytosolic RNA availability. Polypeptide architecture may need hydrophobic, histidine-rich, membrane-active, or other design features that support intracellular trafficking without destabilizing the formulation prematurely.
Cargo-Dependent Behavior: Short siRNA duplexes and long mRNA molecules differ in size, flexibility, and charge distribution. A carrier formulation that works for one RNA format cannot be assumed to transfer directly to another.
Tolerability Tradeoffs: Higher cationic charge can improve RNA binding but may also increase nonspecific membrane interactions. Screening should compare functional delivery with cell health and background effects in the intended research model.
Reproducible Mixing: Order of addition, mixing energy, concentration, and buffer composition can materially affect complex formation. A documented assembly process is essential for comparing formulations across experiments.
Our service modules cover carrier selection, polypeptide design, RNA complexation, formulation screening, physicochemical characterization, and cell-based research evaluation.
When a non-polypeptide benchmark is useful, projects can compare cationic polypeptides with lipid nanoparticles, cationic nanoemulsions, or other delivery approaches from the same internal platform.
Different polypeptide architectures provide different balances of charge, membrane interaction, RNA binding, and formulation flexibility.
| Carrier Concept | Primary Design Feature | Potential Strength | Key Limitation to Watch | Research Fit |
| Poly(L-lysine)-based | Primary amines along a peptide backbone | Strong electrostatic RNA association and straightforward charge tuning | Tight binding, serum interactions, and limited endosomal escape without additional design features | Baseline polyplex studies and carrier modification research |
| Poly(L-arginine)-based | Guanidinium-rich cationic side chains | Strong interaction with nucleic acids and membranes | High cationic density can increase nonspecific interactions | Uptake-oriented feasibility and comparative carrier studies |
| Amphiphilic polypeptide | Cationic and hydrophobic segments | Combines RNA condensation with membrane-interactive character | Hydrophobicity can increase aggregation or reduce solubility | Nanoparticle assembly and intracellular delivery studies |
| pH-responsive polypeptide | Ionizable or protonatable side-chain design | Potential to change interactions across intracellular environments | Behavior is highly composition- and buffer-dependent | Endosomal trafficking and release optimization |
| Hybrid polypeptide system | Polypeptide plus lipid, polymer, or targeting component | Adds functions not provided by charge alone | Higher formulation complexity and more variables to control | Multi-component delivery platform development |
Complex formation is sensitive to both molecular design and processing conditions. These variables are typically optimized together.
| Variable | Why It Matters | Typical Assessment | Failure Pattern | Optimization Direction |
| Charge ratio | Controls RNA association and net particle character | Complexation, size, functional delivery | Free RNA at low ratio or excessive cationic surface at high ratio | Screen a defined ratio series |
| Carrier length | Changes multivalency and packing | Complex stability, size, release behavior | Weak condensation or overly stable complexes | Compare chain-length or molecular-weight variants |
| Hydrophobic content | Can support membrane interaction and self-assembly | Dispersion, size, uptake, release | Aggregation or poor solubility | Adjust hydrophobic fraction or add hydrophilic segments |
| Buffer/ionic strength | Modulates electrostatic interactions | Size drift and visible stability | Salt-induced aggregation or poor reproducibility | Define preparation and dilution buffers |
| Mixing process | Affects nucleation and complex uniformity | Replicate size and functional readout | Batch-to-batch variability | Standardize concentration, order, and mixing energy |
| RNA format | Determines cargo size and flexibility | Complexation and functional delivery | Carrier optimized for one RNA fails for another | Re-optimize formulation for each cargo class |
| Storage/hold time | Can change particle organization | Time-dependent size and activity | Growth, precipitation, or functional loss | Define use window and handling conditions |
The workflow separates carrier design from formulation and functional screening so the source of delivery limitations can be identified more efficiently.
We define RNA type, length, sequence format, concentration needs, research cell model, and functional readout. Existing delivery constraints and benchmark systems are also recorded.
A cationic polypeptide architecture or small carrier panel is selected based on charge density, chain length, hydrophobicity, and desired intracellular behavior.
RNA and carrier are combined across a controlled formulation matrix. Charge ratio, concentration, buffer, and mixing process are varied to identify conditions that produce stable, reproducible complexes.
Lead formulations are assessed for size-related behavior, dispersion stability, and RNA association using methods appropriate to the project. Unstable or overly cationic formulations are deprioritized.
Selected formulations are tested in the intended research model for uptake and RNA-dependent activity, with matched cell-health or background measurements when included.
Data are used to refine carrier composition or formulation conditions. The final package includes preparation instructions, characterization results, functional observations, and recommended next experiments.
Polypeptide carriers provide a modular chemical space for studying how charge, sequence, hydrophobicity, and architecture affect RNA delivery.
Cationic polypeptide systems can support mechanistic and platform-development studies across multiple RNA cargo classes.
Provide the RNA format, research model, target concentration range, and any preferred polypeptide chemistry. We can design a focused carrier and formulation study that balances RNA complexation, particle stability, release, and functional delivery. Contact us to discuss your project requirements.
Positively charged side chains interact electrostatically with the negatively charged phosphate backbone of RNA, allowing the cargo to condense into complexes or nanoparticles.
Poly(L-lysine), poly(L-arginine), amphiphilic cationic polypeptides, and charge- or pH-tunable variants are common research starting points. Selection depends on the RNA cargo and experimental model.
Charge ratio influences RNA association, particle surface properties, stability, and release. Too little carrier may leave RNA insufficiently complexed, while excessive cationic charge can increase nonspecific interactions.
Not reliably. Short siRNA duplexes and long mRNA molecules differ substantially in size, flexibility, and charge distribution, so formulation conditions generally require cargo-specific optimization.
Carrier architectures can incorporate membrane-interactive, hydrophobic, histidine-rich, or other responsive features. These properties need to be balanced with particle stability and cell compatibility.
Loading ......
